1. Intermediate Susceptibility Dose-Dependent Breakpoints For High-Dose Rifampin, Isoniazid, and Pyrazinamide Treatment in Multidrug-Resistant Tuberculosis Programs. (24th April 2018) Authors: Zuur, Marlanka A; Pasipanodya, Jotam G; van Soolingen, Dick; van der Werf, Tjip S; Gumbo, Tawanda; Alffenaar, Jan-Willem C Journal: Clinical infectious diseases Issue: Volume 67:Number 11(2018) Page Start: 1743 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗